trending Market Intelligence /marketintelligence/en/news-insights/trending/Qcd7omv-wyRO4IcAT_idgQ2 content esgSubNav
In This List

Novartis Oncology CEO to retire

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Novartis Oncology CEO to retire

Novartis AG said Novartis Oncology CEO Bruno Strigini will retire for personal reasons.

He will step back from Novartis' executive committee by Dec. 31 and fully hand over in early 2018, the company said in a news release.

Strigini joined Novartis in 2014 as president of oncology and became CEO of the unit in July 2016. He previously served as Merck & Co. Inc.'s president for Europe and Canada.